FITC anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7
C57BL/6 splenocytes stained with IM7 FITC
  • IM7
    C57BL/6 splenocytes stained with IM7 FITC
  • IM7_FITC_060710
    Human peripheral blood lymphocytes stained with IM7 FITC
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103021 25 tests 28,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103005 50 µg 32,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103022 100 tests 76,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103006 500 µg 76,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse, Human, Cross-Reactivity: Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse (Equine), Cattle (Bovine, Cow), Swine (Pig, Porcine), Dog (Canine), Cat (Feline)
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
test size: lot-specific; µg size: 0.5 mg/ml
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, and in vivo inhibition of DTH4,5. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  2. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  3. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  4. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  5. Wang D, et al. 2018. Immunity. 48:659. PubMed
  6. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  7. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  8. Hao J et al. 2018. Cell metabolism. 28(5):689-705 . PubMed
  9. Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed
  10. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  11. Graham JB, et al. 2017. Curr Protoc Mouse Biol. 7:221. PubMed
  12. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  13. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  14. Wang S, et al. 2019. Int J Oncol. 54:966. PubMed
  15. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  16. Matossian MD, et al. 2019. BMC Cancer. 19:205. PubMed
  17. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  18. Ahmed MF, et al. 2019. Exp Ther Med. 17:4154. PubMed
  19. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  20. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  21. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  22. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  23. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  24. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  25. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  26. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  27. Wan X, et al. 2018. Nature. 560:107. PubMed
  28. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  29. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  30. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  31. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  32. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  33. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  34. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  35. Geburek F, et al. 2017. Stem Cell Res Ther. 8:129. PubMed
  36. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  37. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  38. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  39. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  40. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  41. Witschen PM, et al. 2020. Cancers. 12(5):1325. PubMed
  42. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  43. Kamijo S, et al. 2013. J Immunol. 190:4489. PubMed
  44. Murai T, et al. 2013. J Cell Sci. 126:3284. PubMed
  45. Kmieciak M, et al. 2011. Breast Cancer Res Treat. 126:385. PubMed
  46. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  47. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  48. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  49. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  50. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  51. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  52. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  53. Liu Z, et al. 2016. Sci Rep. 6:34416. PubMed
  54. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  55. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  56. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  57. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  58. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  59. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  60. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  61. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  62. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  63. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  64. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  65. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  66. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  67. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  68. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  69. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  70. Dong L, et al. 2021. Cancer Cell. . PubMed
  71. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  72. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  73. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  74. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  75. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  76. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  77. Zhao Y, et al. 2020. Br J Cancer. 1638:122. PubMed
  78. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  79. Israelow B, et al. 2020. bioRxiv. . PubMed
  80. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  81. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  82. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  83. Bi R, et al. 2020. Osteoarthritis Cartilage. 28:842. PubMed
  84. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  85. Amici SA, et al. 2021. Front Immunol. 12:695947. PubMed
RRID
AB_493684 (BioLegend Cat. No. 103021)
AB_312956 (BioLegend Cat. No. 103005)
AB_493685 (BioLegend Cat. No. 103022)
AB_312957 (BioLegend Cat. No. 103006)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 09-11-2014

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account